• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

不同治疗方法对视神经牵引性黄斑病变的脉络膜血管密度指数变化。

Choroidal vascularity index changes in different treatments for vitreomacular traction.

机构信息

Yenimahalle Education and Training Hospital, Yıldırım Beyazıt University, Ankara 06900, Turkey.

Department of Ophthalmology, Baskent University, Ankara, Turkey.

出版信息

Photodiagnosis Photodyn Ther. 2023 Dec;44:103741. doi: 10.1016/j.pdpdt.2023.103741. Epub 2023 Aug 11.

DOI:10.1016/j.pdpdt.2023.103741
PMID:37572736
Abstract

INTRODUCTION

The aim of this study was to examine if choroidal vascularity index (CVI) is different in eyes with unilateral vitreomacular traction (VMT) from their healthy fellow eyes; and whether different treatments affect the CVI.

METHODS

The baseline and 8-week post treatment CVIs of 56 unilateral VMT patients that underwent spontaneous resolution (n = 30), vitreoretinal surgery (n = 16) or pneumatic vitreolysis (n = 10) were compared with fellow eyes using paired samples t-test. Partial correlation analyses correcting age and gender was used for calculations between treatment groups. P values < 0.05 were considered statistically significant.

RESULTS

The mean baseline CVI for VMT and control eyes had no statistically significant difference (p = 0.81, r= -0.38). The post traction release follow-up CVI of VMT eyes and contralateral eyes had no significant difference (p = 0.12, r = 0.49). In spontaneous resolution group, vitreoretinal surgery group and pneumatic vitreolysis group the baseline and follow up CVIs of VMT eyes were statistically similar (p = 0.72, p = 0.32 and p = 0.79 respectively).Spontaneous detachment patients' CVIs showed a 0.57±5.81% increase, vitreoretinal surgery group had a reduction of 1.098±4.76%, and the pneumatic vitreolysis patients showed a CVI reduction of 0.307±4.24%. However, none of these changes was found to be statistically significant when compared between the groups (p = 0.21, r = 0.02).

DISCUSSION

Previous studies have argued that vitreomacular traction might have a role on the choroidal changes seen in the vitreoretinal interface disorders. This study has shown that VMT alone does not cause any significant changes in choroidal vascular index pre or post traction release.

摘要

简介

本研究旨在探讨单侧玻璃体黄斑牵引(VMT)患眼与对侧正常眼的脉络膜血管指数(CVI)是否不同;以及不同治疗方法是否会影响 CVI。

方法

对 56 例单侧 VMT 患者(自发缓解组 n=30 例,玻璃体视网膜手术组 n=16 例,气动玻璃体切除术组 n=10 例)进行基线和 8 周治疗后 CVI 测量,并与对侧眼进行配对样本 t 检验比较。采用偏相关分析校正年龄和性别,比较治疗组之间的相关性。P 值<0.05 为统计学显著差异。

结果

VMT 眼和对照眼的基线 CVI 无统计学差异(p=0.81,r=-0.38)。牵引松解后 VMT 眼和对侧眼的 CVI 无显著差异(p=0.12,r=0.49)。在自发缓解组、玻璃体视网膜手术组和气动玻璃体切除术组中,VMT 眼的基线和随访 CVI 无统计学差异(p=0.72,p=0.32 和 p=0.79 分别)。自发脱离患者的 CVI 增加了 0.57±5.81%,玻璃体视网膜手术组降低了 1.098±4.76%,气动玻璃体切除术组降低了 0.307±4.24%。然而,当组间比较时,这些变化均无统计学意义(p=0.21,r=0.02)。

讨论

既往研究认为玻璃体黄斑牵引可能在玻璃体视网膜界面疾病中引起脉络膜变化。本研究表明,VMT 本身在牵引松解前后不会引起 CVI 显著变化。

相似文献

1
Choroidal vascularity index changes in different treatments for vitreomacular traction.不同治疗方法对视神经牵引性黄斑病变的脉络膜血管密度指数变化。
Photodiagnosis Photodyn Ther. 2023 Dec;44:103741. doi: 10.1016/j.pdpdt.2023.103741. Epub 2023 Aug 11.
2
Correlation of Vitreomacular Traction with Foveal Thickness, Subfoveal Choroidal Thickness, and Vitreomacular/Foveal Angle.玻璃体黄斑牵引与黄斑中心凹厚度、黄斑中心凹下脉络膜厚度及玻璃体黄斑/黄斑中心凹角度的相关性
Curr Eye Res. 2017 Feb;42(2):297-301. doi: 10.1080/02713683.2016.1175020. Epub 2016 Jun 30.
3
PNEUMATIC VITREOLYSIS FOR RELIEF OF VITREOMACULAR TRACTION.用于缓解玻璃体黄斑牵引的气体性玻璃体溶解术
Retina. 2017 Oct;37(10):1820-1831. doi: 10.1097/IAE.0000000000001448.
4
Anatomical and functional outcomes of pneumatic vitreolysis for treatment of vitreomacular traction with and without macular holes.气动玻璃体切割术治疗伴或不伴黄斑裂孔的玻璃体黄斑牵引的解剖和功能结果。
Graefes Arch Clin Exp Ophthalmol. 2022 Jul;260(7):2209-2215. doi: 10.1007/s00417-022-05568-y. Epub 2022 Feb 5.
5
COMBINED PNEUMATIC AND ENZYMATIC VITREOLYSIS FOR SEVERE CASES OF VITREOMACULAR TRACTION.联合气动和酶解玻璃体切除术治疗严重的玻璃体视网膜牵引。
Retin Cases Brief Rep. 2022 Sep 1;16(5):631-636. doi: 10.1097/ICB.0000000000001047.
6
Subfoveal Lucency after Treatment of Vitreomacular Traction without Macular Hole in the Phase 3 Trials of Ocriplasmin Vitreolysis.玻璃体内注射纤溶酶玻璃体溶解术3期试验中无黄斑裂孔的玻璃体黄斑牵引治疗后黄斑中心凹下透亮区
Ophthalmol Retina. 2019 Jan;3(1):42-52. doi: 10.1016/j.oret.2018.05.004. Epub 2018 Jun 28.
7
Quantification of retinal vein and artery trajectories using second-order polynomial equation in eyes with vitreomacular traction.应用二阶多项式方程对伴有玻璃体黄斑牵引的眼中视网膜动静脉轨迹进行量化。
Photodiagnosis Photodyn Ther. 2023 Jun;42:103616. doi: 10.1016/j.pdpdt.2023.103616. Epub 2023 May 17.
8
[Pharmaological vitreolysis with ocriplasmin as a treatment option for symptomatic focal vitreomacular traction with or without macular holes (≤400 μm) compared to tranconjunctival vitrectomy].与经结膜玻璃体切除术相比,使用奥克纤溶酶进行药理玻璃体溶解术作为有症状的局灶性玻璃体黄斑牵引伴或不伴黄斑裂孔(≤400μm)的一种治疗选择
Ophthalmologe. 2017 Feb;114(2):148-154. doi: 10.1007/s00347-016-0322-9.
9
Pneumatic Vitreolysis for the Treatment of Vitreomacular Traction Syndrome.用于治疗玻璃体黄斑牵拉综合征的气体性玻璃体溶解术
Turk J Ophthalmol. 2019 Sep 3;49(4):201-208. doi: 10.4274/tjo.galenos.2019.00400.
10
A novel spectral-domain optical coherence tomography model to estimate changes in vitreomacular traction syndrome.一种用于评估玻璃体黄斑牵引综合征变化的新型光谱域光学相干断层扫描模型。
Graefes Arch Clin Exp Ophthalmol. 2014 Nov;252(11):1729-35. doi: 10.1007/s00417-014-2645-z. Epub 2014 Apr 25.